Characteristics of carbapenem-resistant Pseudomonas aeruginosa strains in patients with ventilator-associated pneumonia in intensive care units.

作者: Astra Vitkauskienė , Erika Skrodenienė , Asta Dambrauskienė , Giedrė Bakšytė , Andrius Macas

DOI: 10.3390/MEDICINA47120095

关键词:

摘要: The aim of this study was to determine the characteristics carbapenem-resistant Pseudomonas aeruginosa (P. aeruginosa) strains and 5-year changes in resistance a tertiary university hospital. Material Methods. included 90 101 randomly selected P. serotyped 2003 2008, respectively. standardized disk diffusion test E-test were used antibiotics. considered have high-level if minimum inhibitory concentration (MIC) for imipenem or meropenem >32 μg/mL. To identify serogroups, sera containing specific antibodies against O group antigens used. isolates resistant or/and screened metallo-β-lactamase (MBL) production by using MBL E-test. Results. Comparison carbapenems within period revealed that level increased. In 2003, 53.3% found be highly imipenem, while percentage increased 87.8% (P=0.01). prevalence MBL-producing from 15.8% 61.9% 2008 (P<0.001). more often ciprofloxacin gentamicin than carbapenem-sensitive strains. carbapenem- additionally ceftazidime, cefepime, aztreonam, piperacillin, amikacin belonged O:11 serogroup MBL-non-producing (51.7% vs. 34.3%, P<0.05). A greater non-MBL-producing had low MICs as compared with Conclusions. results our emphasize need restrict spread usage treat infections intensive care units hospital

参考文章(18)
K Senda, Y Arakawa, K Nakashima, H Ito, S Ichiyama, K Shimokata, N Kato, M Ohta, Multifocal outbreaks of metallo-beta-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems. Antimicrobial Agents and Chemotherapy. ,vol. 40, pp. 349- 353 ,(1996) , 10.1128/AAC.40.2.349
N Woodford, M-F I Palepou, GS Babini, J Bates, DM Livermore, Carbapenemase-producing Pseudomonas aeruginosa in UK The Lancet. ,vol. 352, pp. 546- 547 ,(1998) , 10.1016/S0140-6736(05)79255-2
Jose M. Tellado, Samuel E. Wilson, Empiric treatment of nosocomial intra-abdominal infections: a focus on the carbapenems. Surgical Infections. ,vol. 6, pp. 329- 343 ,(2005) , 10.1089/SUR.2005.6.329
B Cao, H Wang, H Sun, Y Zhu, M Chen, Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections Journal of Hospital Infection. ,vol. 57, pp. 112- 118 ,(2004) , 10.1016/J.JHIN.2004.03.021
Spyros D. Mentzelopoulos, Maria Pratikaki, Evangelia Platsouka, Helen Kraniotaki, Dimitris Zervakis, Antonia Koutsoukou, Serafim Nanas, Olga Paniara, Charis Roussos, Evangelos Giamarellos-Bourboulis, Christina Routsi, Spyros G. Zakynthinos, Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa. Intensive Care Medicine. ,vol. 33, pp. 1524- 1532 ,(2007) , 10.1007/S00134-007-0683-2
J. Patzer, D. Dzierzanowska, The resistance patterns and serotypes of Pseudomonas aeruginosa strains isolated from children Journal of Antimicrobial Chemotherapy. ,vol. 28, pp. 869- 875 ,(1991) , 10.1093/JAC/28.6.869
M. Montero, M. Sala, M. Riu, F. Belvis, M. Salvado, S. Grau, J. P. Horcajada, F. Alvarez-Lerma, R. Terradas, M. Orozco-Levi, X. Castells, H. Knobel, Risk factors for multidrug-resistant Pseudomonas aeruginosa acquisition. Impact of antibiotic use in a double case–control study European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 29, pp. 335- 339 ,(2010) , 10.1007/S10096-009-0850-1
J. L. Trouillet, A. Vuagnat, A. Combes, N. Kassis, J. Chastre, C. Gibert, Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms. Clinical Infectious Diseases. ,vol. 34, pp. 1047- 1054 ,(2002) , 10.1086/339488